Alzheimer’s player AC Immune taps IPO for $58M raise, sees shares soar
Swiss biotech AC Immune followed through on its IPO $ACIU today, pricing at $11 a share. That’s the low end of the range, but …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
